# A First In Human Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Single Rising Doses In Healthy Adult Volunteers

> **NCT00938301** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 18 (actual)

## Conditions studied

- Bipolar Depression

## Interventions

- **DRUG:** PF-04455242
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00938301
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2009-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00938301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00938301, "A First In Human Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Single Rising Doses In Healthy Adult Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00938301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*